Absorption |
Blood-Brain Barrier | BBB+ | 0.8428 |
Human Intestinal Absorption | HIA+ | 0.9743 |
Caco-2 Permeability | Caco2+ | 0.5110 |
P-glycoprotein Substrate | Non-substrate | 0.5494 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9457 |
Non-inhibitor | 0.8040 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9037 |
Distribution |
Subcellular localization | Mitochondria | 0.6982 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7659 |
CYP450 2D6 Substrate | Non-substrate | 0.8824 |
CYP450 3A4 Substrate | Non-substrate | 0.5939 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8750 |
CYP450 2C9 Inhibitor | Inhibitor | 0.5754 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9151 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8838 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.5962 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5000 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9849 |
Non-inhibitor | 0.8649 |
AMES Toxicity | Non AMES toxic | 0.9257 |
Carcinogens | Non-carcinogens | 0.8962 |
Fish Toxicity | High FHMT | 0.9944 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9821 |
Honey Bee Toxicity | High HBT | 0.7203 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.7745 |
Carcinogenicity (Three-class) | Danger | 0.3661 |